#57
Clinical Context
Background information relevant to the evolving cannabis medicine landscape.
This article is not clinically relevant because it discusses ceremonial cacao’s mechanisms rather than cannabis therapeutics, and the anandamide enhancement from cacao is minimal compared to direct cannabinoid administration. Clinicians should be aware that while both cacao and cannabis interact with the endocannabinoid system, the evidence base, dosing precision, and regulatory oversight differ substantially, making cannabis the appropriate choice when endocannabinoid modulation is therapeutically indicated. Patients seeking mood support should understand that cacao’s effects on anandamide are modest and not equivalent to evidence-based cannabis or pharmaceutical treatments for depression or anxiety.
Ceremonial cacao contains compounds that inhibit fatty acid amide hydrolase (FAAH), the enzyme responsible for breaking down anandamide, the endocannabinoid system’s endogenous “bliss molecule.” By slowing anandamide degradation through four distinct biochemical pathways, cacao consumption may enhance endocannabinoid signaling and produce mood-elevating effects comparable to those sought through cannabis use. This mechanism represents a plant-based alternative for modulating the endocannabinoid system without the psychoactive effects of cannabis, potentially offering patients another option for supporting emotional well-being through dietary means. The anandamide-enhancing properties of cacao suggest a physiological basis for its traditional ceremonial use and its modern appeal as a functional food. Clinicians should be aware that patients may be exploring natural endocannabinoid-modulating substances like ceremonial cacao as adjuncts to or substitutes for cannabis or conventional treatments for mood disorders. Patients interested in supporting endocannabinoid tone should understand that cacao offers a legal, accessible option that works through the same signaling system targeted by cannabis.
“The early signals here are worth watching, but we need to be cautious about overstating the clinical significance. While there’s intriguing in-vitro and animal work suggesting cacao compounds may influence anandamide metabolism, we simply don’t have robust human trials yet showing that ceremonial cacao reliably produces meaningful mood changes through this mechanism in a clinical population.”
🧠 While ceremonial cacao’s effects on anandamide metabolism are biochemically plausible, clinicians should exercise caution in translating in vitro enzyme inhibition studies to meaningful clinical mood benefits in patients. The anandamide system’s role in mood regulation is complex and involves numerous downstream effects that may not be fully captured by measuring a single metabolite or enzyme; additionally, the bioavailability of cacao’s active compounds and individual variation in endocannabinoid system function create substantial individual variability in response. Most claims about cacao as a mood-lifting intervention lack rigorous clinical trial evidence, and patients may defer evidence-based treatments for depression or anxiety in favor of dietary interventions. Rather than dismissing cacao’s potential, providers can acknowledge its cultural significance and theoretical mechanisms while emphasizing that for clinically significant mood disorders, cacao should complement rather than replace established therapies, and that patients seeking mood improvement should discuss
💬 Join the Conversation
Have a question about how this applies to your situation?
Ask Dr. Caplan →
Want to discuss this topic with other patients and caregivers?
Join the forum discussion →
Have thoughts on this? Share it:
